FOXA1 and breast carcinoma: For those known breast cancer driver genes such as mutations in TP53, PIK3CA, FOXA1 and amplifications in MYC, ERBB2 and CCND1, again no survival difference was observed to be associated with the presence of such genetic abnormalities.